Andrew C. Weiss
Investor Relations Contact chez IDORSIA LTD
Profil
Andrew C.
Weiss currently works at Idorsia Ltd., as SVP, Head-Corporate Communication & IR from 2017.
Mr. Weiss also formerly worked at Actelion Ltd., as Senior Vice President from 2014 to 2017, Bank Vontobel AG (Research Firm), as Head of Life Sciences Team, Bank Sarasin & Cie AG (Broker), as Research Analyst, and Julius Baer Holding AG, as Fund Manager from 2000 to 2005.
Mr. Weiss received his graduate degree from the University of Zurich.
Postes actifs de Andrew C. Weiss
| Sociétés | Poste | Début |
|---|---|---|
| IDORSIA LTD | Investor Relations Contact | 01/06/2017 |
Anciens postes connus de Andrew C. Weiss
| Sociétés | Poste | Fin |
|---|---|---|
| ACTELION | Investor Relations Contact | 01/01/2017 |
| Bank Sarasin & Cie AG (Broker) | Analyst-Equity | 01/05/2007 |
| Julius Baer Holding AG | Corporate Officer/Principal | 01/01/2005 |
| Bank Vontobel AG (Research Firm) | Analyst-Equity | - |
Formation de Andrew C. Weiss
| University of Zurich | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IDORSIA LTD | Health Technology |
| Entreprise privées | 4 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
| Bank Vontobel AG (Research Firm) | Finance |
| Bank Sarasin & Cie AG (Broker) | Finance |
| Julius Baer Holding AG | Finance |
